2.00 0.03(1.52%)11/19/2024
Inhibikase Therapeutics Inc (IKT)
Ratings - Fundamentals

Rating calculations

CategoryRating
Main RatingC+
Recommended RatingSell
DCFNeutral
ROEStrong Buy
ROAStrong Sell
Debt/EquityStrong Sell
P/EStrong Sell
P/BStrong Sell